Acquired haemophilia A (AHA) is a rare, acquired bleeding disorder characterised by autoantibodies against Factor VIII (FVIII), leading to a variable bleeding phenotype [1]. This evidence concerns the gene F8 and autoimmune hemolytic anemia.